More than 4 billion doses of anti-COVID vaccines have been administered around the world, eight months after the vaccination drive started, according to an AFP count Thursday. Global injections have slowed slightly: this fourth billion was reached in 30 days,…
Read More
Has the billion dollar crusade to eradicate polio come to an end?
The polio juggernaut, which has skidded past eradication deadline after deadline, seems to have finally run out of fuel, suggests an investigation published by The BMJ today. Journalist Robert Fortner reveals that the World Health Organization (WHO) has already fired…
Read More
One billion Covid jabs: a pin-prick of hope for humanity
On December 8, 90-year-old British woman Margaret Keenan, resplendent in her Christmas T-shirt, received the Western world’s first COVID vaccination—a chink of light at the end of the tunnel for humanity after a devastating pandemic year. Six months on, nearly…
Read More
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said Saturday it’s using a combination…
Read More
Dementia prevention strategies could save £1.9 billion annually
Programs to reduce dementia risk by targeting smoking, high blood pressure and hearing loss are likely to be cost-effective and cost saving by reducing dementia rates by 8.5%, finds a new study by UCL and LSE researchers. The modeling study,…
Read More
$15 billion revenue loss projected for US primary care due to COVID-19 shutdowns
Primary care practices are projected to lose more than $65,000 in revenue per full-time physician in 2020, following drastic declines in office visits and fees for services from March to May during the COVID-19 pandemic, according to a study led…
Read More